Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1992 Mar;87(3):404–409. doi: 10.1111/j.1365-2249.1992.tb03010.x

An association between homozygous C3 deficiency and low levels of anti-pneumococcal capsular polysaccharide antibodies.

M A Hazlewood 1, D S Kumararatne 1, A D Webster 1, M Goodall 1, P Bird 1, M Daha 1
PMCID: PMC1554319  PMID: 1544226

Abstract

Inherited deficiencies of complement components are associated with an increased risk of infection by encapsulated, high grade bacterial pathogens such as Streptococcus pneumoniae, Haemophilus influenzae type b and Neisseria meningitidis. Hence, the levels of antibodies to bacterial capsular polysaccharide antigens were measured using ELISA in 65 patients with inherited deficiencies covering the classical, alternative and terminal components of the complement cascade. Three of the four C3-deficient individuals studied were found to be almost totally deficient in specific anti-pneumococcal capsular polysaccharide (PCP) antibodies. These individuals had a history of recurrent pneumococcal sepsis. While single individuals with C1r, C2 and C1Inh deficiency were found to have low anti-PCP antibody levels, no other group of complement deficiency had significantly reduced anti-PCP antibody levels compared with 100 controls. Antibody levels to the other two polysaccharides were not significantly lower in the patient groups. These findings suggest that C3 may be able to provide a stimulatory signal to promote the production of anti-PCP antibodies.

Full text

PDF
404

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper C. A., Colten H. R., Gear J. S., Rabson A. R., Rosen F. S. Homozygous human C3 deficiency. The role of C3 in antibody production, C-1s-induced vasopermeability, and cobra venom-induced passive hemolysis. J Clin Invest. 1976 Jan;57(1):222–229. doi: 10.1172/JCI108263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ambrosino D. M., Umetsu D. T., Siber G. R., Howie G., Goularte T. A., Michaels R., Martin P., Schur P. H., Noyes J., Schiffman G. Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels. J Allergy Clin Immunol. 1988 Jun;81(6):1175–1179. doi: 10.1016/0091-6749(88)90887-1. [DOI] [PubMed] [Google Scholar]
  3. Amir J., Liang X., Granoff D. M. Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b. Pediatr Res. 1990 Apr;27(4 Pt 1):358–364. doi: 10.1203/00006450-199004000-00008. [DOI] [PubMed] [Google Scholar]
  4. Bird P., Lachmann P. J. The regulation of IgG subclass production in man: low serum IgG4 in inherited deficiencies of the classical pathway of C3 activation. Eur J Immunol. 1988 Aug;18(8):1217–1222. doi: 10.1002/eji.1830180811. [DOI] [PubMed] [Google Scholar]
  5. Bohnsack J. F., Cooper N. R. CR2 ligands modulate human B cell activation. J Immunol. 1988 Oct 15;141(8):2569–2576. [PubMed] [Google Scholar]
  6. Botto M., Fong K. Y., So A. K., Rudge A., Walport M. J. Molecular basis of hereditary C3 deficiency. J Clin Invest. 1990 Oct;86(4):1158–1163. doi: 10.1172/JCI114821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Böttger E. C., Hoffmann T., Metzger S., Hadding U., Bitter-Suermann D. The role and mechanism of cobra venom factor-induced suppression of the humoral immune response in guinea pigs. J Immunol. 1986 Aug 15;137(4):1280–1285. [PubMed] [Google Scholar]
  8. Davis A. E., 3rd, Davis J. S., 4th, Rabson A. R., Osofsky S. G., Colten H. R., Rosen F. S., Alper C. A. Homozygous C3 deficiency: detection of C3 by radioimmunoassay. Clin Immunol Immunopathol. 1977 Nov;8(3):543–550. doi: 10.1016/0090-1229(77)90019-8. [DOI] [PubMed] [Google Scholar]
  9. Dintzis H. M., Dintzis R. Z., Vogelstein B. Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3671–3675. doi: 10.1073/pnas.73.10.3671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Einstein L. P., Hansen P. J., Ballow M., Davis A. E., 3rd, Davis J. S., 4th, Alper C. A., Rosen F. S., Colten H. R. Biosynthesis of the third component of complement (C3) in vitro by monocytes from both normal and homozygous C3-deficient humans. J Clin Invest. 1977 Nov;60(5):963–969. doi: 10.1172/JCI108876. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Fine D. P. Pneumococcal type-associated variability in alternate complement pathway activation. Infect Immun. 1975 Oct;12(4):772–778. doi: 10.1128/iai.12.4.772-778.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fingeroth J. D., Heath M. E., Ambrosino D. M. Proliferation of resting B cells is modulated by CR2 and CR1. Immunol Lett. 1989 Jun 15;21(4):291–301. doi: 10.1016/0165-2478(89)90022-9. [DOI] [PubMed] [Google Scholar]
  13. Gray B. M. ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes. J Immunol Methods. 1979;28(1-2):187–192. doi: 10.1016/0022-1759(79)90340-5. [DOI] [PubMed] [Google Scholar]
  14. Griffioen A. W., Rijkers G. T., Janssens-Korpela P., Zegers B. J. Pneumococcal polysaccharides complexed with C3d bind to human B lymphocytes via complement receptor type 2. Infect Immun. 1991 May;59(5):1839–1845. doi: 10.1128/iai.59.5.1839-1845.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hammarström L., Smith C. I. IgG subclasses in bacterial infections. Monogr Allergy. 1986;19:122–133. [PubMed] [Google Scholar]
  16. Hostetter M. K. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis. 1986 Apr;153(4):682–693. doi: 10.1093/infdis/153.4.682. [DOI] [PubMed] [Google Scholar]
  17. Jefferis R., Kumararatne D. S. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol. 1990 Sep;81(3):357–367. doi: 10.1111/j.1365-2249.1990.tb05339.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Jefferis R., Reimer C. B., Skvaril F., de Lange G., Ling N. R., Lowe J., Walker M. R., Phillips D. J., Aloisio C. H., Wells T. W. Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett. 1985;10(3-4):223–252. doi: 10.1016/0165-2478(85)90082-3. [DOI] [PubMed] [Google Scholar]
  19. Johnson E., Hetland G. Mononuclear phagocytes have the potential to synthesize the complete functional complement system. Scand J Immunol. 1988 May;27(5):489–493. doi: 10.1111/j.1365-3083.1988.tb02375.x. [DOI] [PubMed] [Google Scholar]
  20. Kuypers T. W., Roos D. Leukocyte membrane adhesion proteins LFA-1, CR3 and p150,95: a review of functional and regulatory aspects. Res Immunol. 1989 Jun-Aug;140(5-6):461–486. doi: 10.1016/0923-2494(89)90114-4. [DOI] [PubMed] [Google Scholar]
  21. MacLennan I. C., Liu Y. J., Oldfield S., Zhang J., Lane P. J. The evolution of B-cell clones. Curr Top Microbiol Immunol. 1990;159:37–63. doi: 10.1007/978-3-642-75244-5_3. [DOI] [PubMed] [Google Scholar]
  22. Matsuda T., Martinelli G. P., Osler A. G. Studies on immunosuppression by cobra venom factor. II. On responses to DNP-Ficoll and DNP-Polyacrylamide. J Immunol. 1978 Nov;121(5):2048–2051. [PubMed] [Google Scholar]
  23. Moxon E. R., Kroll J. S. The role of bacterial polysaccharide capsules as virulence factors. Curr Top Microbiol Immunol. 1990;150:65–85. doi: 10.1007/978-3-642-74694-9_4. [DOI] [PubMed] [Google Scholar]
  24. Mäkelä O., Mattila P., Rautonen N., Seppälä I., Eskola J., Käyhty H. Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid). J Immunol. 1987 Sep 15;139(6):1999–2004. [PubMed] [Google Scholar]
  25. Noah N. D. Vaccination against pneumococcal infection. BMJ. 1988 Nov 26;297(6660):1351–1352. doi: 10.1136/bmj.297.6660.1351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. O'Neil K. M., Ochs H. D., Heller S. R., Cork L. C., Morris J. M., Winkelstein J. A. Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J Immunol. 1988 Mar 15;140(6):1939–1945. [PubMed] [Google Scholar]
  27. Pepys M. B. Role of complement in induction of antibody production in vivo. Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J Exp Med. 1974 Jul 1;140(1):126–145. doi: 10.1084/jem.140.1.126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Pepys M. B. Role of complement in induction of the allergic response. Nat New Biol. 1972 May 31;237(74):157–159. doi: 10.1038/newbio237157a0. [DOI] [PubMed] [Google Scholar]
  29. Pryjma J., Humphrey J. H. Prolonged C3 depletion by cobra venom factor in thymus-deprived mice and its implication for the role of C3 as an essential second signal for B-cell triggering. Immunology. 1975 Mar;28(3):569–576. [PMC free article] [PubMed] [Google Scholar]
  30. Rasmussen J. M., Teisner B., Brandslund I., Svehag S. E. A family with complement factor I deficiency. Scand J Immunol. 1986 Jun;23(6):711–715. doi: 10.1111/j.1365-3083.1986.tb02008.x. [DOI] [PubMed] [Google Scholar]
  31. Roord J. J., Daha M., Kuis W., Verbrugh H. A., Verhoef J., Zegers B. J., Stoop J. W. Inherited deficiency of the third component of complement associated with recurrent pyogenic infections, circulating immune complexes, and vasculitis in a Dutch family. Pediatrics. 1983 Jan;71(1):81–87. [PubMed] [Google Scholar]
  32. Rosen F. S. T cell : B cell collaboration--the response to polysaccharide antigens. Semin Immunol. 1989 Sep;1(1):87–91. [PubMed] [Google Scholar]
  33. Ross S. C., Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine (Baltimore) 1984 Sep;63(5):243–273. [PubMed] [Google Scholar]
  34. Rother K. Summary of reported deficiencies. Prog Allergy. 1986;39:202–211. [PubMed] [Google Scholar]
  35. Schur P. H. IgG subclasses--a review. Ann Allergy. 1987 Feb;58(2):89-96, 99. [PubMed] [Google Scholar]
  36. Servis C., Lambris J. D. C3 synthetic peptides support growth of human CR2-positive lymphoblastoid B cells. J Immunol. 1989 Apr 1;142(7):2207–2212. [PubMed] [Google Scholar]
  37. Shackelford P. G., Granoff D. M., Nelson S. J., Scott M. G., Smith D. S., Nahm M. H. Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol. 1987 Jan 15;138(2):587–592. [PubMed] [Google Scholar]
  38. Timens W., Boes A., Rozeboom-Uiterwijk T., Poppema S. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response. J Immunol. 1989 Nov 15;143(10):3200–3206. [PubMed] [Google Scholar]
  39. Weinberg G. A., Granoff D. M., Nahm M. H., Shackelford P. G. Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae. J Immunol. 1986 Jun 1;136(11):4232–4236. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES